Head of Research Group

•  Researcher ID
• CV
• Publications

---

 

Senior Scientist

• CV
• Publications

---

 

PostDoc

• CV
• Publications

---

 

Technical Assistance

• Publications

---

 

PhD Students

My fascination with science began early and led me to pursue a BSc in Bioengineering with a specialization in Applied Biotechnology at the Hungarian University of Agriculture and Life Sciences in Budapest, where I graduated in 2021. During my bachelor’s studies, I spent one semester abroad through the Erasmus program at Wageningen University in the Netherlands. I continued my education with a Master’s degree in Medical Biology at the University of Salzburg, which I completed in 2025. Alongside my academic studies, I consistently worked in professional settings to gain hands-on experience. I spent two years as a laboratory analyst at EGIS, a leading pharmaceutical company and part of the Servier Group, where I honed my analytical skills. After completing my bachelor’s degree, I joined Pharmgenetix, an innovative molecular diagnostics startup focused on personalized medicine. Over the course of more than three years, I worked there as a laboratory technician, contributing to both routine analytics and research projects. I also conducted the research for my Master’s thesis at Pharmgenetix, titled “Investigation of the Functional Consequences of CYP2D6 Promoter Polymorphisms on Gene Expression.”. 

• Publications

Paul earned his Bachelor of Engineering (B.Eng.) degree in 2016 from the Munich University of Applied Sciences. During his bachelor thesis, he worked at the Institute for Translational Cardiac Surgery at the German Heart Centre Munich, where he focused on investigating the direct reprogramming of murine primary fibroblasts into induced cardiac progenitor cells. For his Master’s studies, Paul moved to the Technical University of Munich, completing a Master of Science (M.Sc.) in Molecular Biotechnology in 2024. As part of his academic journey, he undertook a six-month industrial internship in the Cell Technologies department at Roche in Penzberg and participated in a semester abroad at the Faculty of Sciences, University of Lisbon. His master thesis was conducted at the Institute of Molecular Oncology and Functional Genomics at TranslaTUM, where he worked on validating a CasRx-based lncRNA screening platform. In 2025, Paul joined Silja Weßler’s group, where his research focuses on developing organoid-based advanced infection models for carcinogenic pathogens.

I am a PhD candidate within the EpiFlaMe consortium, focusing on stomach-specific epigenetic memory that predisposes tissue to inflammation-driven gastric cancer. I am particularly interested in how external factors cause cells to shift their identities, and am convinced that understanding this is key to future prevention and treatment. Before starting my PhD, I completed the Joint Bachelor’s (2023) and Master’s (2026) Degrees at the Paris Lodron University of Salzburg and Johannes Kepler University Linz. For my Master’s Thesis, I gained experience in organoid culture and infection experiments during a six-month studentship at the University of Oxford. I later returned to Oxford to further expand my research experience through their summer school program. Beyond my research, I enjoy spending time in nature, exploring cozy hobbies, and trying out new things. I am also actively involved in a Women’s Health Circle, where I help host informal discussions on topics ranging from biology and health to broader questions of society.

 

---

MasterstudentInnen

---

StudienassistentInnen